Natural Cycles Raises $55 Million in Series C Funding Round - Revolutionizing Digital Birth Control

Natural Cycles°, the pioneering health tech company renowned for developing the only regulated digital birth control method endorsed by both the US FDA and CE in Europe, is thrilled to announce the successful closure of a $55 million funding round. This significant capital infusion underscores the growing recognition of Natural Cycles° as a transformative force in women's health and reproductive autonomy. The funding will be strategically allocated towards enhancing our mobile application, expanding our research endeavors, and scaling our marketing efforts, aimed at empowering more women globally to understand their bodies and cycles better while taking control of their reproductive health. Founded in 2013 by visionaries Elina and Raoul, Natural Cycles° has catered to an increasing user base who value the effectiveness of an evidence-based, non-hormonal birth control alternative. Our innovative algorithm utilizes advanced mathematics and data analytics to accurately predict ovulation and fertility, bridging the gap between science and women's health needs. Since receiving CE certification in February 2017, our commitment to continuous improvement and innovation has never wavered. We believe that every woman deserves to fully understand her menstrual cycle, regardless of the birth control method she chooses. The recent funding milestone empowers us to further our goal of driving awareness and adoption of our solution, while fostering a deeper connection with our users. As we continue this journey, we're eager to welcome passionate talents who share our commitment to pioneering change in this complex and critical field of women's health. Join us as we lead the way in revolutionizing how women manage their reproductive health!